Abstract:Background: Recent epidemiological studies have indicated a correlation between platelet indices and pulmonary arterial hypertension (PAH), yet the causality between them remains unclear. To explore the causal relationship between four platelet indices and PAH, with the aim of providing a theoretical basis for clinical prevention and treatment. Methods: Single-nucleotide polymorphisms (SNPs) associated with platelet-related traits were selected as exposure factors from published genome-wide association studies (GWAS), including: platelet count (PLT), plateletcrit (PCT), mean platelet volume (MPV), and platelet distribution width (PDW). Summary-level data for PAH were obtained from the FinnGen study (248 cases and 289,117 controls). Two-sample and multivariable Mendelian randomization (MR) analyses were conducted to assess the causal relationship between exposure factors and the risk of outcomes. The inverse variance weighted (IVW) method was utilized as the primary MR analysis approach, supplemented by weighted median, mode-based estimation, MR-Egger regression, and the MR Pleiotropy Residual Sum and Outlier (MR-PRESSO) test to detect and adjust for pleiotropy, ensuring the reliability of the results through sensitivity analysis. Results: (1) The IVW results from the two-sample MR analysis showed a positive causal association between PLT and the risk of developing PAH [(OR = 1.649, 95%CI: 1.206-2.256, P = 0.0017)], with the sensitivity analysis confirming the robustness of the causal relationship. The MR-Egger intercept analysis did not detect potential pleiotropy (P = 0.879). (2) The MVMR results showed no statistically significant causal relationship between these four markers and the risk of developing PAH. After adjusting for collinearity, a direct positive causal association was observed between PLT and the risk of developing PAH (OR = 1.525, 95%CI: 1.063-2.189, P = 0.022). Conclusion: The positive correlation between PLT and the risk of PAH suggests that correcting elevated platelet levels may reduce the risk of developing PAH.

Causal associations between telomere length and pulmonary arterial hypertension: A two-sample Mendelian randomization study

Identification of a Novel Mutation in the BMPR2 Gene in a Pulmonary Arterial Hypertension Patient Using Next‐generation Sequencing

Epigenetic Regulation of Pulmonary Arterial Hypertension

Genes in pediatric pulmonary arterial hypertension and the most promising BMPR2 gene therapy

Molecular genetic framework underlying pulmonary arterial hypertension

Assessing causal associations of blood counts and biochemical indicators with pulmonary arterial hypertension: a Mendelian randomization study and results from national health and nutrition examination survey 2003–2018

Causal relationship between immune cells and pulmonary arterial hypertension: Mendelian randomization analysis

Serum uric acid and pulmonary arterial hypertension: A two-sample Mendelian randomization study

Platelet indices and the risk of pulmonary arterial hypertension: a two-sample and multivariable Mendelian randomization study

[Genetic, cellular and molecular mechanisms of pulmonary arterial hypertension]

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

Causal effects between gut microbiota and pulmonary arterial hypertension: A bidirectional Mendelian randomization study

Mendelian randomization study on causal association of TEF and circadian rhythm with pulmonary arterial hypertension

Association between Genotype, Presentation, and Outcome in Childhood Idiopathic and Hereditary Pulmonary Arterial Hypertension

Genetically determined gut microbiota associates with pulmonary arterial hypertension: a Mendelian randomization study

Causal association of depression, anxiety, cognitive performance, the brain cortical structure with pulmonary arterial hypertension: A Mendelian randomization study

Genetic liability to asthma and risk of cardiovascular diseases: A Mendelian randomization study

No genetic causal association between iron status and pulmonary artery hypertension: Insights from a two‐sample Mendelian randomization

Epigenetic Inheritance of Telomere Length Obscures Identification of Causative PARN Locus.

Causal association between epigenetic age acceleration and two pulmonary vascular diseases: pulmonary arterial hypertension and pulmonary embolism—a bidirectional Mendelian study

Identifying potential causal effects of telomere length on health outcomes: A phenome-wide investigation and Mendelian randomization study